Published in Headache on November 21, 2011
Survey of migraine sufferers with dogs to evaluate for canine migraine-alerting behaviors. J Altern Complement Med (2012) 0.75
Cutaneous allodynia in the migraine population. Ann Neurol (2008) 2.75
Square one: headache education for the medical student. Headache (2007) 2.34
Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention study. Headache (2007) 2.09
Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy. Headache (2004) 1.76
Memantine in the preventive treatment of refractory migraine. Headache (2008) 1.54
Survey of retail milk composition as affected by label claims regarding farm-management practices. J Am Diet Assoc (2008) 1.48
Diagnostic criteria for headache due to spontaneous intracranial hypotension: a perspective. Headache (2011) 1.40
Central sensitization theory of migraine: clinical implications. Headache (2006) 1.40
Consensus statement: cardiovascular safety profile of triptans (5-HT agonists) in the acute treatment of migraine. Headache (2004) 1.39
Is botulinum toxin useful in treating headache? Yes. Curr Treat Options Neurol (2009) 1.38
Can allodynic migraine patients be identified interictally using a questionnaire? Neurology (2005) 1.31
Pharmacology of dihydroergotamine and evidence for efficacy and safety in migraine. Headache (2006) 1.27
Choosing wisely in headache medicine: the American Headache Society's list of five things physicians and patients should question. Headache (2013) 1.17
DHE in the pharmacotherapy of migraine: potential for a larger role. Headache (2006) 1.17
Botulinum toxin type A for the treatment of headache: why we say yes. Arch Neurol (2008) 1.14
Measuring migraine-related quality of care across 10 health plans. Am J Manag Care (2012) 1.08
Resolution of sleepiness and fatigue in major depressive disorder: A comparison of bupropion and the selective serotonin reuptake inhibitors. Biol Psychiatry (2006) 1.08
Seasonal affective disorder and its prevention by anticipatory treatment with bupropion XL. Biol Psychiatry (2005) 1.08
Satisfaction with current migraine therapy: experience from 3 centers in US and Sweden. Headache (2007) 1.02
Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of major depressive disorder with high levels of anxiety (anxious depression): a pooled analysis of 10 studies. J Clin Psychiatry (2008) 1.01
Insights into the mechanism of onabotulinumtoxinA in chronic migraine. Headache (2011) 1.00
Prevalence of COPD among symptomatic patients in a primary care setting. Curr Med Res Opin (2009) 0.97
Cardiovascular tolerability and safety of triptans: a review of clinical data. Headache (2004) 0.96
A randomized double-blind study comparing rizatriptan, dexamethasone, and the combination of both in the acute treatment of menstrually related migraine. Headache (2008) 0.95
Reversible anorgasmia with topiramate therapy for headache: a report of 7 patients. Headache (2006) 0.93
Primary headaches: a convergence hypothesis. Headache (2002) 0.92
Intravenous lidocaine in the treatment of refractory headache: a retrospective case series. Headache (2009) 0.92
Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of anxiety symptoms in major depressive disorder: a meta-analysis of individual patient data from 10 double-blind, randomized clinical trials. J Psychiatr Res (2007) 0.91
The evolution of chronic migraine: classification and nomenclature. Headache (2009) 0.91
Extended-release bupropion for patients with major depressive disorder presenting with symptoms of reduced energy, pleasure, and interest: findings from a randomized, double-blind, placebo-controlled study. J Clin Psychiatry (2006) 0.90
Efficacy of rizatriptan for menstrual migraine in an early intervention model: a prospective subgroup analysis of the rizatriptan TAME (Treat A Migraine Early) studies. Headache (2007) 0.89
Oral zolmitriptan in the short-term prevention of menstrual migraine: a randomized, placebo-controlled study. CNS Drugs (2008) 0.88
Migraine prophylaxis with botulinum toxin A is associated with perception of headache. Toxicon (2009) 0.88
Efficacy and tolerability of zolmitriptan oral tablet in the acute treatment of menstrual migraine. CNS Drugs (2006) 0.88
Sudden unexpected death in epilepsy in lamotrigine randomized-controlled trials. Epilepsia (2012) 0.87
The impact of topiramate on health-related quality of life indicators in chronic migraine. Headache (2007) 0.87
Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies. J Clin Psychiatry (2006) 0.86
Evaluation of an electronic diary as a diagnostic tool to study headache and premenstrual symptoms in migraineurs. Headache (2007) 0.86
Treating early versus treating mild: timing of migraine prescription medications among patients with diagnosed migraine. Headache (2005) 0.85
Patients' preference for migraine preventive therapy. Headache (2007) 0.85
Double-blind, placebo-controlled comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR. J Psychopharmacol (2009) 0.85
A randomized, double-blind, placebo-controlled study of the effect of sustained-release bupropion on blood pressure in individuals with mild untreated hypertension. J Clin Psychopharmacol (2008) 0.84
Quality of care measures for migraine: a comprehensive review. Dis Manag (2007) 0.84
Does early migraine treatment shorten time to headache peak and reduce its severity? Headache (2007) 0.84
Relief of menstrual symptoms and migraine with a single-tablet formulation of sumatriptan and naproxen sodium. J Womens Health (Larchmt) (2014) 0.83
Twelve-month tolerability and efficacy study of NP101, the sumatriptan iontophoretic transdermal system. Headache (2012) 0.83
Migraine frequency and health utilities: findings from a multisite survey. Value Health (2008) 0.82
Changes in salivary prostaglandin levels during menstrual migraine with associated dysmenorrhea. Headache (2010) 0.82
Role of melatonin in the pathophysiology of migraine: implications for treatment. CNS Drugs (2006) 0.82
Safety and tolerability of short-term preventive frovatriptan: a combined analysis. Headache (2009) 0.82
Inpatient treatment of headache: an evidence-based assessment. Headache (2004) 0.82
Can migraineurs accurately identify their headaches as "migraine" at attack onset? Headache (2007) 0.81
Meta-analysis of suicidality in placebo-controlled clinical trials of adults taking bupropion. Prim Care Companion J Clin Psychiatry (2010) 0.81
Headache attributed to psychiatric disorders. Handb Clin Neurol (2010) 0.81
Menstrual migraine: a review of hormonal causes, prophylaxis and treatment. Expert Opin Pharmacother (2007) 0.81
Episodic migraine associated with postural orthostatic tachycardia syndrome and vasovagal syncope: migraine triggers neuromediated syncope. Arq Neuropsiquiatr (2008) 0.81
Valdecoxib for treatment of a single, acute, moderate to severe migraine headache. Headache (2005) 0.80
Use of common migraine treatments in breast-feeding women: a summary of recommendations. Headache (2013) 0.80
Topiramate intervention to prevent transformation of episodic migraine: the topiramate INTREPID study. Cephalalgia (2010) 0.80
Repression of stimulated calcitonin gene-related peptide secretion by topiramate. Headache (2006) 0.80
Pharmacological synergy: the next frontier on therapeutic advancement for migraine. Headache (2012) 0.80
Efficacy and safety of tamsulosin for benign prostatic hyperplasia: clinical experience in the primary care setting. Curr Med Res Opin (2006) 0.80
Effect of bupropion SR on specific symptom clusters of depression: analysis of the 31-item Hamilton Rating Scale for depression. Psychopharmacol Bull (2003) 0.79
Predictability of future attacks by migraineurs: a prospective observational study. Headache (2010) 0.79
A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults. Clin Ther (2006) 0.79
Migraine therapy: a survey of pharmacists' knowledge, attitudes, and practice patterns. Headache (2005) 0.79
Development of a simple menstrual migraine screening tool for obstetric and gynecology clinics: the menstrual migraine assessment tool. Headache (2008) 0.79
Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies. Headache (2004) 0.79
Initiating and optimizing acute therapy for migraine: the role of patient-centered stratified care. Am J Med (2005) 0.78
Lower-dose diclofenac submicron particle capsules provide early and sustained acute patient pain relief in a phase 3 study. Postgrad Med (2013) 0.77
The quality of headache treatment in the United States: review and analysis of recent data. Headache (2005) 0.77
Frovatriptan as preemptive treatment for fasting-induced migraine. Headache (2011) 0.77
Assessing quality of care for migraineurs: a model health plan measurement set. Popul Health Manag (2008) 0.77
Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study. Headache (2006) 0.77
Combination therapy in acute migraine treatment: the rationale behind the current treatment options. Postgrad Med (2006) 0.77
A randomized, placebo-controlled trial of the analgesic efficacy and safety of the p38 MAP kinase inhibitor, losmapimod, in patients with neuropathic pain from lumbosacral radiculopathy. Clin J Pain (2015) 0.77
Migraine headache misconceptions: barriers to effective care. Pharmacotherapy (2004) 0.77
Comparing the rapidity of response during treatment of major depressive disorder with bupropion and the SSRIs: a pooled survival analysis of 7 double-blind, randomized clinical trials. J Clin Psychiatry (2007) 0.76
Diagnosis and management of migraine in family practice. J Fam Pract (2004) 0.76
Prevalence of migraine and response to sumatriptan in patients self-reporting tension/stress headache. Curr Med Res Opin (2006) 0.76
The COX-2 specific inhibitor Valdecoxib versus tramadol in acute ankle sprain: a multicenter randomized, controlled trial. Am J Sports Med (2006) 0.76
Is there a preferred triptan? Headache (2002) 0.76
An open-label study to assess changes in efficacy and satisfaction with migraine care when patients have access to multiple sumatriptan succinate formulations. Clin Ther (2003) 0.76
Migraine and cognition. Headache (2013) 0.75
Mixing sumatriptan. Headache (2002) 0.75
Multiple intracerebral hemorrhages after cervical epidural injections. Neurology (2008) 0.75
Stress and migraine. Headache (2009) 0.75
Relative antidepressant efficacy of bupropion and the selective serotonin reuptake inhibitors in major depressive disorder: gender-age interactions. Int Clin Psychopharmacol (2007) 0.75
John Edmeads celebration of a life (April 15, 1936-November 16, 2006). Headache (2007) 0.75
Expanding access to triptans: assessment of clinical outcome. Headache (2009) 0.75
Comparing the efficacy of eletriptan for migraine in women during menstrual and non-menstrual time periods: a pooled analysis of randomized controlled trials. Headache (2013) 0.75
An update on migraine pathophysiology and mechanism-based pharmacotherapeutics for migraine. Postgrad Med (2006) 0.75
Acute migraine treatment with rizatriptan in real world settings - focusing on treatment strategy, effectiveness, and behavior. Headache (2009) 0.75
Cluster headache treatment dilemmas: the experts respond. Curr Pain Headache Rep (2007) 0.75
Key factors in the primary care diagnosis of migraine. Expert Rev Neurother (2002) 0.75
Considerations in the treatment of tension-type headache in the elderly. Drugs Aging (2014) 0.75
Sublingual feverfew/ginger (LipiGesic M) reanalysis of data. Headache (2013) 0.75